Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Saroglitazar

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,673Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Torrent, Zydus in co-marketing pact for liver disease drug Saroglitazar
    Torrent, Zydus in co-marketing pact for liver disease drug Saroglitazar

    10 Nov 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/torrent-zydus-in-co-marketing-pact-for-liver-disease-drug-saroglitazar/articleshow/105124905.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    10 Nov 2023
    Share Share
    Zydus starts trial to generate data on effect of Saroglitazar in NAFLD patients
    Zydus starts trial to generate data on effect of Saroglitazar in NAFLD patients

    09 Jun 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-starts-trial-to-generate-data-on-effect-of-saroglitazar-mg-in-nafld-patients/articleshow/100874481.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    09 Jun 2023
    Share Share
    NAFLD clinical trial activity catching up in Chin, lacks domestic participation
    NAFLD clinical trial activity catching up in Chin, lacks domestic participation

    27 Dec 2022

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/nafld-clinical-trial-activity-catching-up-in-china-but-lacks-substantial-domestic-participation-says-globaldata-13507

    INDIANPHARMAPOST
    27 Dec 2022
    Share Share
    Zydus announces EPICS-IIITM phase-II(b)/III adaptive pivotal clinical trial
    Zydus announces EPICS-IIITM phase-II(b)/III adaptive pivotal clinical trial

    10 Dec 2021

    // EXPRESS PHARMA

    https://www.expresspharma.in/zydus-announces-epics-iiitm-phase-iib-iii-adaptive-pivotal-clinical-trial-of-saroglitazar-mg-in-pbc/

    EXPRESS PHARMA
    10 Dec 2021
    Share Share
    Zydus announces EPICS-IIITM ph-II(b)/III adaptive pivotal trial of Saroglitazar
    Zydus announces EPICS-IIITM ph-II(b)/III adaptive pivotal trial of Saroglitazar

    09 Dec 2021

    // EXPRESS PHARMA

    https://www.expresspharma.in/zydus-announces-epics-iiitm-phase-iib-iii-adaptive-pivotal-clinical-trial-of-saroglitazar-mg-in-pbc/

    EXPRESS PHARMA
    09 Dec 2021
    Share Share
    European Medicines Agency grants Orphan Drug Designation to Zydus Cadila's Saroglitazar Mg
    European Medicines Agency grants Orphan Drug Designation to Zydus Cadila's Saroglitazar Mg

    20 Jul 2021

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/european-medicines-agency-grants-orphan-drug-designation-to-zydus-cadilas-saroglitazar-mg/articleshow/84610016.cms

    ECONOMIC TIMES
    20 Jul 2021
    Share Share